Quarterly report pursuant to Section 13 or 15(d)

Revision of Prior Period Financial Statements (Tables)

v3.21.1
Revision of Prior Period Financial Statements (Tables)
3 Months Ended
Mar. 31, 2021
Restatement [Abstract]  
Summary of Restatement of Balance Sheet
The effect of the adjustments on the line items within the Company’s consolidated balance sheet as of December 31, 2020 is as follows:
 
    
December 31, 2020
 
    
As
previously
reported
    
Adjustment
    
As adjusted
 
Inventories
   $ 30,292      $ (4,841 )     $ 25,451  
Current Assets
     50,464        (4,841 )       45,623  
Total Assets
     357,974        (4,841 )       353,133  
Accrued and other current liabilities
     56,381        (1,328 )       55,053  
Current liabilities
     233,207        (1,328 )       231,879  
Total Liabilities
     307,132        (1,328 )       305,804  
Accumulated Deficit
     (720,629 )       (3,513 )       (724,142 ) 
Total Shareholders’ Equity
     50,842        (3,513 )       47,329  
Total Liabilities and Shareholders’ Equity
     357,974        (4,841 )       353,133  
Summary of Restatement of Statement of Equity
T
he effect of the adjustments on the line items within the Company’s interim condensed consolidated statements of shareholder’s equity for the three months ended March 31, 2021 is as follow
s:
 
    
March 31, 2021
 
    
As
previously
reported
    
Adjustment
    
As adjusted
 
Deficit accumulated – Balance January 1, 2021
   $ (720,629 )     $ (3,513 )     $ (724,142 ) 
Shareholders’ equity total – Balance January 1, 2021
     50,842        (3,513 )       47,329